We shall entertain new funding presentations as follows:
- 8:30 - 9:00 AM, Relavo, A novel connection device that reduces the risk of infection in Peritoneal dialysis (PD), a home-based treatment for kidney failure.
- 9:15- 9:45 AM, EMBioSys, therapeutic wearable garments that utilize low level induced electric fields (iEFs) for treatment of solid metastatic cancers.
Beacon portfolio updates:
- 10:00 - 10:20 AM, QSM Diagnostics, Providing novel technology to rapidly and accurately diagnose bacterial infections in pets
Members shall report on pending funding rounds, by Series number.
- 112B Theromics developing tumor-targeting therapies;
- 116B Realplay providing video highlights for youth sports
- 122 GelMedix improving drug delivery for the eye; and
- 126 myBiometry developing an advanced early-warning system for asthma attacks.
- 127 Agile Devices a novel microcatheter with a deflectble tip for challenging anatomy
Members will report on companies now in due diligence:
- AI Lean (Dave Smith)
- AGED Diagnostics (Kevin Richard)